Mayo Clinic to Offer CAR T-Cell Therapy for Relapsed Non-Hodgkin LymphomaNewswise (press release)Newswise — ROCHESTER, Minn. – Mayo Clinic announced today that its Rochester campus is one of 16 cancer centers nationally selected to provide chimeric ant… Continue reading
Historic Partnership Grant Advances Immunotherapy Research of Mary Markiewicz, Ph.D., at the University of Kansas …Newswise (press release)"This is a type of immunotherapy where you take immune cells out of the patient, in this case natural kill… Continue reading
Science DailyStem cells conduct cartilage regeneration but are not directly involvedScience DailyStem cell therapy has great potential for curing cartilage damage. However, it has remained unclear whether stem cells are responsible for regeneration or … Continue reading
Medical Xpress |
Gene therapy protects against age-related cognitive and memory deficits
Medical Xpress Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d”Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … Kogenix Licenses Gene Therapy for Prevention of Age-Related Dementia and Alzheimer’sDigital Journal |
Medical Xpress |
Editing false positives from cancer dependency maps drawn with CRISPR
Medical Xpress Genome-scale CRISPR-based knockout screens are powerful tools for pinpointing cells’ genetic dependencies—that is, genes that cells require for their survival and/or proliferation. However, such CRISPR screens are sensitive to a phenomenon called the … |
Boston Business Journal |
Sarepta jumps into the CRISPR fray with Duke gene-editing pact
Boston Business Journal Sarepta (Nasdaq: SRPT) said it had reached an agreement to exclusively license technology related to CRISPR/Cas9 from Duke University. Researchers there, led by Dr. Charles Gersbach, have shown that the technology can be used in mice to remove … Expanding its preclinical attack on Duchenne MD, Sarepta grabs a license for Duke’s CRISPR techEndpoints News Sarepta Therapeutics (SRPT) Signs Exclusive Global Collaboration with Duke University for Gene Editing CRISPR …StreetInsider.com Sarepta inks research collaboration with Duke University for use of gene editing technology to restore dystrophin …Seeking Alpha |